Page: Medicines for human use under evaluation-2025/12/5

Document: Applications for new human medicines under evaluation: December 2025-2025/12/5

Page: Annex to the European Commission guideline on 'Excipients in the labelling and package leaflet of medicinal products for human use'-2025/12/5

Document: All languages - Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668) - Revision 5-2025/12/5

Page: Interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU - Scientific guideline-2025/12/4

Document: Explanatory note on the withdrawal of the interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU-2025/12/4

Page: CHMP opinions on consultation procedures-2025/12/4

Document: Consultation on an ancillary medicinal substance incorporated in a medical device - Gynemed GmbH & Co. KG HSA-containing ART media-2025/12/4

Document: Consideration on core requirements for RMPs of COVID-19 vaccines-2025/12/4

Page: Availability of medicines before and during crises-2025/12/4